High-Dose heart drug tested for stroke recovery
NCT ID NCT01976936
Summary
This study tested the safety of giving a very high dose of a common cholesterol-lowering drug (lovastatin) for just three days right after someone has a stroke. Researchers wanted to see if this short, intense treatment was safe for the liver and muscles, and if it might help people recover better from their stroke. The study involved 162 people who had recently suffered a stroke and were randomly assigned to receive either the high-dose drug or a placebo.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STROKE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Brigham & Women's Hospital
Boston, Massachusetts, 02115, United States
-
Emory University
Atlanta, Georgia, 30322, United States
-
Jackson Memorial Hospital
Miami, Florida, 33136, United States
-
Mount Sinai School of Medicine
New York, New York, 10029, United States
-
The Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
-
University of California, Los Angeles Stroke Network
Los Angeles, California, 90024, United States
-
University of Miami Miller School of Medicine
Miami, Florida, 33136, United States
Conditions
Explore the condition pages connected to this study.